The Global
Erectile Dysfunction Market was valued at US$ 4,129.5
million in 2015 and is projected to expand at a CAGR of 0.2% during
the forecast period (2016–2024),as highlighted in a new
report published by Coherent Market Insights. Growing
prevalence of sexual disease and increasing geriatric population are
major factor expected to drive growth of the global erectile
dysfunction market.
Erectile dysfunction was earlier believed to be a
condition mainly prevalent among elderly men. However, a recent study
conducted by medical institution across the globe, explains that the
erectile dysfunction also affects younger men, due to sex hormone
imbalance at the early stage of their puberty. There are many
medications available to treat erectile dysfunction that are
especially effective among young men, as they are can easily absorb
the drugs content and show quick effects when compared to men aged
above 60 years.Erectile dysfunction may involve several different
medical conditions of reproductive health and sexual dysfunction.
Attaining an erection is a one of the multipart process which
involves the brain, sex hormones, nerves, muscles, and blood
circulation and any deviation or interference from the normal
erection process may lead to erectile dysfunction. In some cases at
older age of 55-60 years, ED shows a multiple health problem such as
cardiovascular problems, which necessitates immediate treatment, as
this may also cause a risk factors for heart attacks and strokes.
To know the latest trends and insights
prevalent in the erectile dysfunction market, click the link below:
Globally around 5% of male who are aged 40 years
have a strong or complete erectile dysfunction, and this increases to
around 15% of males aged 70 years. Nearly 10% of men in the age group
of 50–70 years suffer mild or moderate erectile dysfunction in
their life. According to Medical Journal of Sexual Medicine, erectile
dysfunction can occur at any age, though it is more prominent among
men aged above 60 years. People over 60 years suffer from large
number of health conditions when compared to young people and with
the weak immune system, any hindrance in hormonal process may need
medication, further leads to sexual inability. Moreover, as men age,
the erectile stimulation and sexual ability becomes weak. Medication
such as Cialis and Viagra are highly prescribed drugs in the erectile
dysfunction market.
Fill the form for an exclusive sample of
Erectile Dysfunction Market report @
https://www.coherentmarketinsights.com/insight/request-sample/200
Increasing prevalence of male sexual dysfunction
in the highly populous Asia region is a major factor driving growth
of the erectile dysfunction market. For instance, in 2011, the
prevalence percentage of erectile dysfunction in China was 45%, South
Korea 32.3%, Malaysia 26.8%, Thailand 37.5%, and Singapore 51.5%.
According to UK Health Center, 1 in 10 men worldwide suffer from
erectile dysfunction and more than half of all diabetic men suffer
from erectile dysfunction. Over 20 million people globally are
prescribed Viagra to treat erectile dysfunction, and out of this 66%
of people who are administered or prescribed Viagra, are able to have
sexual intercourse. Around 48% of this group suffer from one or more
side-effects from Viagra.
Key takeaways of the erectile dysfunction
market:
-
The global erectile dysfunction market is expected to expand at a CAGR of 0.2% during the forecast period (2016–2024) as there still exists a major unrealized market, especially in Africa and Middle East countries.
-
The Cialis product dominates the erectile dysfunction market in by product segment as it is the primary drug prescribed by many physicians globally because of high therapeutic efficacy and lower price
Get An Exclusive Discount For First Time Buyers@
https://www.coherentmarketinsights.com/insight/request-discount/200
-
Some of the major players involved in global erectile dysfunction market are Meda Pharmaceuticals, Inc, Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical System, Boston Scientific Corporation, and Vivus, Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
No comments:
Post a Comment